Literature DB >> 7232968

Treatment of narcolepsy and sleep apnea with gammahydroxybutyrate: a clinical and polysomnographic case study.

M Mamelak, P Webster.   

Abstract

Gammahydroxybutyrate was administered to a patient who experienced narcolepsy associated with central sleep apnea. The treatment relieved the major symptoms of narcolepsy, and significantly decreased the number of apneic periods. Gammahydroxybutyrate did not cause the prolonged and potentially fatal apneic periods associated with the use of other hypnotic agents.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7232968     DOI： 10.1093/sleep/4.1.105

Source DB:  PubMed          Journal:  Sleep        ISSN： 0161-8105            Impact factor:   5.849


  3 in total

1.  Sodium oxybate and breathing.

Authors:  Juan Jose Ortega-Albas; Roberto López-Bernabé; Jose Ramón Diaz; Angel Luis Serrano
Journal:  Sleep Breath       Date:  2009-11-27       Impact factor: 2.816

2.  Catathrenia under sodium oxybate in narcolepsy with cataplexy.

Authors:  Francesca Poli; Lara Ricotta; Stefano Vandi; Christian Franceschini; Fabio Pizza; Vincenzo Palaia; Keivan Kaveh Moghadam; Donatella Banal; Roberto Vetrugno; Michael J Thorpy; Giuseppe Plazzi
Journal:  Sleep Breath       Date:  2011-04-12       Impact factor: 2.816

3.  Metabolism of [U-14C]-4-hydroxybutyric acid to intermediates of the tricarboxylic acid cycle in extracts of rat liver and kidney mitochondria.

Authors:  K M Gibson; W L Nyhan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jan-Mar       Impact factor: 2.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.